The Carlyle Group Inc. 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-02 5:01 pm Sale | 2023-07-18 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 1,872,764 4.200% | -544,073 (-22.51%) | Filing |
| 2023-07-05 4:17 pm Sale | 2023-06-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,416,837 5.500% | -543,394 (-18.36%) | Filing |
| 2023-04-13 4:06 pm Sale | 2023-03-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,960,231 6.700% | -9,925 (-0.33%) | Filing |
| 2022-08-11 5:01 pm Purchase | 2022-08-01 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,970,156 11.100% | 2,970,156 (New Position) | Filing |